Ad
related to: gilead sciences- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- Top Clean Energy Stocks
How to profit from surging demand.
Free report reveals 5 hot stocks.
- Chipmaker Set to Soar Now
Search results
Gilead Sciences: Native Health Navigator Program Connects
3BL CSRwire· 1 day agoOlivia Sloan was pursuing a career in health policy and research when her father was diagnosed with...
Taking a look at what insiders are doing to gauge the Gilead Sciences, Inc.
Knox Daily· 7 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares ...
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks· 7 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. During this period, the Zacks Medical - Biomedical and Genetics industry, which Gilead falls in, has lost 0.4% ...
Gilead’s FOCUS Program Helps Zero In on Early HIV
3BL CSRwire· 6 days agoA 22-year-old college student who didn’t feel well was treated at an urgent care facility in Baton Rouge, Louisiana and expected to recover soon. When the test came back positive, the student ...
Decoding Gilead Sciences's Options Activity: What's the Big Picture? - Gilead Sciences (NASDAQ:GILD)
Benzinga· 6 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead</ ...
Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
InvestorPlace· 6 hours agoPenny stocks to buy understandably offer many enticing attributes, not least of which is the...
California Supreme Court to Review Newly Created Duty to Market a “Safer” Product Even in the...
JD Supra· 7 days agoOn May 1, the California Supreme Court granted Gilead Science Inc.’s request to review a California appellate court’s holding that the pharmaceutical manufacturer ...
One stock is dragging down the S&P 500's earnings growth
AOL· 3 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers Squibb (BMY). Last month ...
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
Reuters via Yahoo News· 1 day agoThe U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks· 7 days agoMaking its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE Quick QuotePBE - Free Report) provides investors broad exposure to the Health Care ETFs ...